These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 30026408)
1. [Clinical Practice of Carcinoma of Unknown Primary]. Hasegawa Y; Mukai H Gan To Kagaku Ryoho; 2018 Jun; 45(6):891-893. PubMed ID: 30026408 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic and therapeutic management of cancer of an unknown primary. Pavlidis N; Briasoulis E; Hainsworth J; Greco FA Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453 [TBL] [Abstract][Full Text] [Related]
4. Cancer of unknown primary site: review of consecutive cases at the National Cancer Center Hospital of Japan. Yakushiji S; Ando M; Yonemori K; Kohno T; Shimizu C; Katsumata N; Fujiwara Y Int J Clin Oncol; 2006 Dec; 11(6):421-5. PubMed ID: 17180509 [TBL] [Abstract][Full Text] [Related]
5. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology. Alberti C G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of cancer of unknown primary, today and future]. Shibata H Gan To Kagaku Ryoho; 2009 Jun; 36(6):918-22. PubMed ID: 19542712 [TBL] [Abstract][Full Text] [Related]
10. Insights from the genetic and transcriptional characterization of a cancer of unknown primary (CUP). Davalos V; Esteller M EMBO Mol Med; 2020 Jul; 12(7):e12685. PubMed ID: 32558182 [TBL] [Abstract][Full Text] [Related]
12. Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study. Pentheroudakis G; Briasoulis E; Kalofonos HP; Fountzilas G; Economopoulos T; Samelis G; Koutras A; Karina M; Xiros N; Samantas E; Bamias A; Pavlidis N; Acta Oncol; 2008; 47(6):1148-55. PubMed ID: 18607872 [TBL] [Abstract][Full Text] [Related]
13. [Metastases of unknown origin--principles of diagnosis and treatment]. Petrović D; Muzikravić L; Jovanović D Med Pregl; 2007; 60(1-2):29-36. PubMed ID: 17853708 [TBL] [Abstract][Full Text] [Related]
14. [Diagnostic approach to cancer of unknown primary site]. Fernández Cotarelo MJ; Guerra Vales JM Rev Clin Esp; 2009; 209(7):347-51. PubMed ID: 19709540 [TBL] [Abstract][Full Text] [Related]
15. One-hour paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of carcinoma of unknown primary site. Greco FA; Hainsworth JD Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-101-S19-105. PubMed ID: 9427278 [TBL] [Abstract][Full Text] [Related]
16. Management of patients with cancer of unknown primary site. Hainsworth JD; Greco FA Oncology (Williston Park); 2000 Apr; 14(4):563-74; discussion 574-6, 578-9. PubMed ID: 10826316 [TBL] [Abstract][Full Text] [Related]
17. Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy. Yonemori K; Ando M; Shibata T; Katsumata N; Matsumoto K; Yamanaka Y; Kouno T; Shimizu C; Fujiwara Y J Cancer Res Clin Oncol; 2006 Oct; 132(10):635-42. PubMed ID: 16791594 [TBL] [Abstract][Full Text] [Related]
18. Cancer of Unknown Primary origin in the genomic era: Elucidating the dark box of cancer. Economopoulou P; Mountzios G; Pavlidis N; Pentheroudakis G Cancer Treat Rev; 2015 Jul; 41(7):598-604. PubMed ID: 26033502 [TBL] [Abstract][Full Text] [Related]
19. Poorly differentiated neoplasms of unknown primary site: diagnostic usefulness of a molecular cancer classifier assay. Greco FA; Lennington WJ; Spigel DR; Hainsworth JD Mol Diagn Ther; 2015 Apr; 19(2):91-7. PubMed ID: 25758902 [TBL] [Abstract][Full Text] [Related]